Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

TRVITRVI
6 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in Trevi Therapeutics, Inc.

WELLINGTON MANAGEMENT GROUP LLP holds 5.7M shares of TRVI (Trevi Therapeutics, Inc.), worth $106M as of 2026-Q2. The position was increased (+9.6% shares). TRVI represents 0.0% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$106M

Current Shares

5.7M

Total Value Change

+$105.2M

Total Shares Change

+5.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.7M
+9.6%
$106M0.0%$18.65
33
2026-Q1
Increased
5.2M
+52.4%
$61.9M0.0%$12.26
41
2025-Q4
Increased
3.4M
+4.6%
$42.6M0.0%$12.56
31
2025-Q3
Increased
3.3M
+1792.0%
$29.8M0.0%$8.95
46
2025-Q2
Increased
171,982
+34.9%
$940,7420.0%$5.62
32
2025-Q1
New
127,452
-
$801,6730.0%$6.50
34

Other major holders of TRVI: FMR LLC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used